H5N1 Avian Flu Spreads Globally: 986 Human Cases, 463 Deaths Reported Worldwide in Ongoing Pandemic Threat
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
H5N1 Avian Flu Spreads Globally: 986 Human Cases, 463 Deaths Reported Worldwide in Ongoing Pandemic Threat
-
ナレーター：
-
著者：
このコンテンツについて
Avian flu, specifically H5N1, remains a relentless presence across continents. In the Americas, the Pan American Health Organization notes that from late 2023 through early 2025, outbreaks have been reported in 14 countries, with the United States seeing 109 poultry outbreaks across 32 states in just the first two months of this year, and ongoing spread in wild birds and some mammals. South American countries like Peru and Argentina have reported multiple animal outbreaks since the beginning of 2025.
Asia sees continued human cases. The World Health Organization recently reported 11 laboratory-confirmed H5N1 infections in Cambodia between January and July 1, 2025, primarily from exposure to sick backyard poultry. Since 2003, globally, there have been 986 human cases and 463 deaths, a strikingly high case fatality ratio, though WHO currently assesses general population risk as low. Bangladesh also saw new human cases this July.
Europe continues to combat the virus mainly in birds. The European Centre for Disease Prevention and Control counted 365 H5N1 virus detections in domestic and wild birds in 24 countries between March and June 2025. Human infections in Europe remain rare, but surveillance is intense.
Africa’s outbreaks persist, especially where poultry farming is prevalent. Animal cases in Egypt and West Africa have led to international trade restrictions and culls to stem the spread.
International cooperation is vital. WHO and the Food and Agriculture Organization emphasize rapid virus detection and data sharing. According to the FAO, there have been 677 animal outbreaks in the current wave since October 2024, spanning five geographic regions. WHO insists immediate reporting of any novel human H5N1 infection to help global risk assessment. The CDC and ECDC track the spread and genetic shifts in the virus, vital for pandemic preparedness.
Research is accelerating. Major initiatives focus on mapping mutations that could enhance transmission between mammals or to humans. There’s an expanded effort to develop broad-spectrum antivirals and universal flu vaccines.
Vaccine development is underway globally. China, the United States, and Europe are supporting several candidate vaccines now in clinical evaluation, but as of July 2025, no universal H5N1 vaccine for humans is approved for mass use. Some countries, notably in East Asia, maintain stockpiles of poultry vaccines to manage animal outbreaks.
Trade impacts are profound. Outbreaks prompt swift bans on poultry exports, hitting farmers and disrupting international chicken and egg markets. Cross-border issues emerge as migratory birds spread the virus beyond political boundaries, posing challenges for coordinated containment.
Countries take different approaches. The U.S. and EU emphasize culling and surveillance. Southeast Asia focuses more on vaccination and biosecurity among smallholders. Trade and response are further complicated by differing compensation schemes for affected farmers and varied access to diagnostics.
As avian influenza adapts, the need for global vigilance, transparent reporting, and coordinated research has never been clearer.
Thank you for tuning in to H5N1 Global Scan: Avian Flu Worldwide. Come back next week for another international deep dive. This has been a Quiet Please production – for more, visit QuietPlease.AI.
For more http://www.quietplease.ai
Get the best deals https://amzn.to/3ODvOta